tiprankstipranks
Trending News
More News >
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Cash flow

Compare
432 Followers

TransCode Therapeutics Cash Flow

RNAZ's free cash flow for Q3 2025 was $-4.08M. For the 2025 fiscal year, RNAZ's free cash flow was decreased by $4.75M and operating cash flow was $-4.08M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -13.34M$ -18.07M$ -15.76M$ -5.27M$ -492.97K
Investing Cash Flow
$ -21.76K$ -35.61K$ -100.92K$ -251.82K$ 0.00
Financing Cash Flow
$ 16.40M$ 15.91M$ 5.99K$ 25.52M$ 1.12M
End Cash Position
$ 5.81M$ 2.77M$ 4.97M$ 20.83M$ 828.02K
Free Cash Flow
$ -13.36M$ -18.11M$ -15.86M$ -5.52M$ -492.97K
Currency in USD

TransCode Therapeutics Cash Flow